Lactobacillus reuteri LR92


Lactobacillus reuteri LR 92 LR92 is the first and only probiotic strain that has clinically demonstrated to significantly reduce the incidence of infantile colic in the newborn child, when given, to the mothers, in the last months of pregnancy. By improving the health of the infant, LR 92 helps mothers to live more serenely during the initial months after pregnancy, reducing the stress associated with their child’s crying. The low efficacy dosage of 0,1 billion CFU/day allows for LR92 to be easily incorporated into existing pre-natal formulations which include other vital nutrients for pregnant mothers.

Scientific reference(s)

Additional info

Therapeutical area(s)

Gastrointestinal tract




Children · Women
Scroll to Top
Browse companies by type
Brought to you by